Oxidative Stress in Type 2 Diabetes: The Case for Future Pediatric Redoxomics Studies

• Published in: Antioxidants Vol. 11; no. 7; p. 1336
• Main Authors: Alu, Stephanie N., Los, Evan A., Ford, George A., Stone, William L.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 07.07.2022; MDPI
• Subjects: Antioxidants; Calories; Carbohydrates; Children; Diabetes; Diabetes mellitus (non-insulin dependent); Diet; Environmental factors; Exercise; Fatty acids; Food consumption; Glucose; Hydrogen peroxide; Insulin; Insulin resistance; Kinases; Lipids; Meals; Metabolism; Metabolomics; Mitochondria; Musculoskeletal system; Oils & fats; Oxidative stress; Pathophysiology; Pediatrics; Phosphorylation; Physical activity; Physical fitness; Plasma; Proteins; Proteomics; Reactive oxygen species; redoxomics; Review; Risk assessment; Risk factors; Skeletal muscle; Teenagers
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox11071336

Considerable evidence supports the role of oxidative stress in adult type 2 diabetes (T2D). Due to increasing rates of pediatric obesity, lack of physical activity, and consumption of excess food calories, it is projected that the number of children living with insulin resistance, prediabetes, and T2D will markedly increase with enormous worldwide economic costs. Understanding the factors contributing to oxidative stress and T2D risk may help develop optimal early intervention strategies. Evidence suggests that oxidative stress, triggered by excess dietary fat consumption, causes excess mitochondrial hydrogen peroxide emission in skeletal muscle, alters redox status, and promotes insulin resistance leading to T2D. The pathophysiological events arising from excess calorie-induced mitochondrial reactive oxygen species production are complex and not yet investigated in children. Systems medicine is an integrative approach leveraging conventional medical information and environmental factors with data obtained from “omics” technologies such as genomics, proteomics, and metabolomics. In adults with T2D, systems medicine shows promise in risk assessment and predicting drug response. Redoxomics is a branch of systems medicine focusing on “omics” data related to redox status. Systems medicine with a complementary emphasis on redoxomics can potentially optimize future healthcare strategies for adults and children with T2D.